Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aqua Bio Technology ASA (OSTO:ABTO) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Aqua Bio Technology ASA's Enterprise Value for the quarter that ended in Dec. 2025 was kr183.79 Mil.
Aqua Bio Technology ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aqua Bio Technology ASA EV-to-EBIT Related Terms
Aqua Bio Technology ASA EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:ABTO vs VRTX, REGN, RVMD: EV-to-EBIT Comparison
For the Biotechnology subindustry, Aqua Bio Technology ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aqua Bio Technology ASA EV-to-EBIT vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Aqua Bio Technology ASA's EV-to-EBIT falls into.
Aqua Bio Technology ASA's current Enterprise Value is kr171.69 Mil.
Aqua Bio Technology ASA's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-1.53 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aqua Bio Technology ASA (OSTO:ABTO) has a EV-to-EBIT of -112.15 as of Aug. 05, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aqua Bio Technology ASA and its competitors. According to the industry distribution chart, Aqua Bio Technology ASA ranks #999999 out of 381 companies in the Biotechnology industry.
Is Aqua Bio Technology ASA's EV-to-EBIT too high?
Aqua Bio Technology ASA's current EV-to-EBIT is -112.15. Based on the distribution chart, Aqua Bio Technology ASA ranks #999999 out of 381 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Aqua Bio Technology ASA has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's EV-to-EBIT compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Aqua Bio Technology ASA ranks #999999 out of 381 companies for EV-to-EBIT. This places Aqua Bio Technology ASA in the lower half of its industry. The industry median EV-to-EBIT is 13.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Biotechnology company?
The median EV-to-EBIT among Biotechnology companies is 13.65, based on 381 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Aqua Bio Technology ASA and its competitors. For the Biotechnology industry, the median EV-to-EBIT is 13.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aqua Bio Technology ASA's current EV-to-EBIT is -112.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Aqua Bio Technology ASA (OSTO:ABTO) has a current EV-to-EBIT of -112.15. The stock's GF Value™ is kr4.32, compared to a current price of kr6.82 — trading 57.9% above its estimated fair value. The current EV-to-EBIT is -112.15. Aqua Bio Technology ASA's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Aqua Bio Technology ASA (OSTO:ABTO), the current EV-to-EBIT is -112.15 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aqua Bio Technology ASA (OSTO:ABTO) Overvalued in 2026?
Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued.
The current stock price of kr6.82 is trading 57.9% above its estimated GF Value™ of kr4.32.
Key valuation signals for OSTO:ABTO:
EV-to-EBIT: -112.15
GF Value™: kr4.32 vs. price of kr6.82 (57.9% above fair value)
No single metric tells the full story. See the OSTO:ABTO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
43GF Score
Get the complete analysis for OSTO:ABTO
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ABTO has been successfully added to your 
